SEC Form 4 · accession 0001571049-16-010590
PHIBRO ANIMAL HEALTH CORP · PAHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Larry Lee Miller
Officer — President
Period of report
Jan 5, 2016
Accepted (ET)
Jan 7, 2016 · 9:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001069899
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Jan 5, 2016 | M | 2,850 | $11.83 | A | 2,850 | D | |
| Class A Common StockF2 | Jan 5, 2016 | S | 2,850 | $30.16 | D | 0 | D | |
| Class A Common Stock | Jan 6, 2016 | M | 1,622 | $11.83 | A | 1,622 | D | |
| Class A Common Stock | Jan 6, 2016 | S | 1,622 | $30.00 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to purchase Class A Common Stock | $11.83 | Jan 5, 2016 | M | 2,850 | D | Apr 29, 2013 | Feb 28, 2019 | Class A Common Stock | 2,850 | 489,650 | D |
| Option to purchase Class A Common Stock | $11.83 | Jan 6, 2016 | M | 1,622 | D | Apr 29, 2013 | Feb 28, 2019 | Class A Common Stock | 1,622 | 488,028 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 12, 2015.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.35, inclusive.